COMMUNIQUÉS West-GlobeNewswire

First Medical Patent Issued for the Oculenz™ Augmented Reality Glasses
12/06/2018
Ocutrx™ AR Glasses Garners First Medical Patent for Restoring Functional Sight to Patients with Visual Field Deficits IRVINE, Calif., June 12, 2018 (GLOBE NEWSWIRE) -- Ocutrx Vision Technologies, LLC, a California based [...]
William Demant Holding A/S: Investor news - agenda and presentations for Capital Markets Day 2018
12/06/2018
Investor news 12 June 2018 Agenda and presentations for Capital Markets Day 2018 William Demant Holding A/S will today host its Capital Markets Day 2018 in London with the following agenda: 09:30 Registration 10:00 [...]
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
12/06/2018
FIT Biotech Oy Company release June 12, 2018 at 10:00 AM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on December 22, 2017 [...]
Sentia Medical Sciences Inc. Appoints Dr. Yvette Taché as Chair of the Scientific Advisory Board and Announces Award of a Phase 1 Small Business Innovation Research (SBIR) Grant to Develop Astressins for the Treatment of Irritable Bowel Syndrome (IBS)
12/06/2018
SAN DIEGO, June 12, 2018 (GLOBE NEWSWIRE) -- Sentia announced today the appointment of Dr. Yvette Taché, Ph.D. as Chair of the Scientific Advisory Board. Dr. Taché, Ph.D. is a Distinguished Professor in the Vatche and [...]
Solon Eiendom ASA : Primary insider notification
12/06/2018
(Oslo, Norway, June 11, 2018) UFI AS has today bought 15.145 shares in Solon Eiendom ASA at a price of NOK 30.027 per share. Solon Eiendom ASA Board Member Øystein A. Landvik owns 33,34 % of the shares in UFI AS. [...]
Shire plc : Rule 2.9 Announcement
12/06/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 12 June 2018 Shire [...]
FIT Biotech Oy: First EHVA clinical trial authorization granted for testing FIT-06
12/06/2018
FIT Biotech Oy Company release 12.6.2018 at 8:30 AM EET First EHVA clinical trial authorization granted for testing FIT-06 FIT Biotech Oy ("Company", FITBIO: FN Finland) today announced that the Swiss medical [...]
European Select Growth Opportunities Fund subscribes to the 19th tranche of its investment today and has agreed to provide up to EUR 7.25 million in additional funding
12/06/2018
Amsterdam, The Netherlands - 12 June 2018 Esperite N.V. (Euronext: ESP, " Esperite " or the " Group ") announces today the issuance to European Select Growth Opportunities Fund (the " Investor " or " ESGO ") of the 19th [...]
Curetis To Attend Key Investor and Scientific Conferences In The Third Quarter 2018
12/06/2018
Curetis To Attend Key Investor and Scientific Conferences In The Third Quarter 2018 Amsterdam, the Netherlands, San Diego, CA, USA and Holzgerlingen, Germany , June 12, 2018 , 01:00 a.m. EST -- Curetis N.V. (the " [...]
Santhera Submits NDA in South Korea for Raxone® for the Treatment of LHON
12/06/2018
Pratteln, Switzerland, June 12, 2018 - Santhera Pharmaceuticals (SIX: SANN) announces that the Korean Ministry of Food and Drug Safety (MFDS) has accepted for review Santhera's new drug application (NDA) for Raxone® ( [...]
argenx to host KOL breakfast symposium on immune thrombocytopenia on June 19, 2018
12/06/2018
June 12, 2 018 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the [...]
Acasti Pharma Reports on Positive Feedback Following Today’s Presentation at the XVIII International Symposium on Atherosclerosis
12/06/2018
LAVAL, Québec, June 11, 2018 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (NASDAQ:ACST) (TSX-V:ACST) (the “ Company ” or “ Acasti Pharma ”), a biopharmaceutical innovator focused on the research, development and [...]
Compass Cannabis Clinics Launches International Venture
12/06/2018
CALGARY, Alberta, June 11, 2018 (GLOBE NEWSWIRE) -- 10330698 Canada Ltd. (dba Compass Cannabis Clinics, "Compass") is pleased to announce that it has entered into a letter of intent with Dr. Teresa Towpik which will [...]
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12/06/2018
CAMBRIDGE, Mass., June 11, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to treat [...]
IntelGenx Grants Stock Options
11/06/2018
SAINT LAURENT, Quebec, June 11, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. ("IntelGenx", or the “Company”) (TSX-V:IGX) (OTCQX:IGXT) announced today that the Company’s board of directors granted options to [...]
Project HOPE Responds to Urgent Health Needs from Guatemala’s Fuego Volcano
11/06/2018
Millwood, VA, June 11, 2018 (GLOBE NEWSWIRE) -- Project HOPE announced the deployment of an emergency medical response team to Guatemala as fresh lava flows from the Fuego volcano, prolonging a disaster that has [...]
N.M. Judge Rejects NMDOH Sanction for Seedling at State Fair
11/06/2018
Judge David K. Thomson rules NMDOH sanction is arbitrary and capricious SANTA FE, N.M., June 11, 2018 (GLOBE NEWSWIRE) -- District Judge David. K Thomson reversed the New Mexico Department of Health (NMDOH) sanction [...]
Surface Oncology to be Added to the Russell 3000 Index and Russell 2000 Index
11/06/2018
CAMBRIDGE, Mass., June 11, 2018 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today [...]
Clearside Biomedical to Participate in 2018 JMP Securities Life Sciences Conference
11/06/2018
ALPHARETTA, Ga., June 11, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]

Pages